HomeInsightsEPS

Suven Pharmaceuticals Ltd EPS

Suven Pharmaceuticals Ltd EPS

stocks purchased

₹ 1.6 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

12.8 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Suven Pharmaceuticals Ltd

NSE: SUVENPHAR

EPS

₹ 9.45

Last updated on: Nov 07, 2024

Key Highlights

  • The Earning per Share of Suven Pharmaceuticals Ltd is ₹ 9.45 as of 07 Nov 24.
  • The Earning per Share of Suven Pharmaceuticals Ltd changed from ₹ 4.22 to ₹ 2.39 over 9 quarters. This represents a CAGR of -22.33% .

Historical Earning per Share of Suven Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Suven Pharmaceuticals Ltd

Market Cap

32,667 Cr

EPS

9.4

P/E Ratio (TTM) *

135.8

P/B Ratio (TTM) *

15.9

Day’s High *

1320.15

Day’s Low

1277.45

DTE *

0.0

ROE *

14.6

52 Week High

1358.75

52 Week Low

542.35

ROCE *

19.5

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Suven Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20241283.25
06 Nov 20241325.35
05 Nov 20241333.1
04 Nov 20241319.65
01 Nov 20241328.65
31 Oct 20241315.5
30 Oct 20241274.05
29 Oct 20241278
28 Oct 20241256.9
25 Oct 20241248.3

SWOT Analysis Of Suven Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Suven Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Suven Pharmaceuticals Ltd

Market Value

32,667

Asset Value

494

65.2 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Suven Pharmaceuticals Ltd932,667
Sun Pharmaceuticals Industries Ltd464,29,841
Divis Laboratories Ltd631,58,179
Cipla Ltd571,27,063
Mankind Pharma Ltd521,09,234
Dr Reddys Laboratories Ltd631,07,398

Historical Market Cap of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Suven Pharmaceuticals Ltd News Hub

News

Suven Pharmaceuticals to conduct EGM

Suven Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

30 Oct 202414:53

News

Suven Pharmaceuticals to convene board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 N...

Read more

27 Sep 202410:46

News

Suven Pharmaceuticals appoints Vivek Sharma as new Executive Chairman

Suven Pharmaceuticals announced the appointment of Vivek Sharma as the new Executive Chair...

Read more

19 Sep 202419:41

News

Board of Suven Pharmaceuticals approves change in Executive Chairperson

The Board of Suven Pharmaceuticals at its meeting held on 19 September 2024 has taken on r...

Read more

19 Sep 202419:28

News

Suven Pharmaceuticals to hold board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 Au...

Read more

06 Aug 202417:05

News

Suven Pharmaceuticals to conduct AGM

Suven Pharmaceuticals announced that the 6th Annual General Meeting (AGM) of the company w...

Read more

15 Jul 202417:27

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

June 2024

TranscriptPPT

June 2023

TranscriptPPT

Feb 2023

Transcript

Dec 2022

Transcript

Nov 2022

Transcript

June 2022

Transcript

Feb 2022

PPT

Nov 2021

PPT

Aug 2021

PPT

June 2021

TranscriptPPT

Dec 2020

Transcript

Oct 2020

PPT

June 2020

PPT

FAQs for EPS of Suven Pharmaceuticals Ltd

What is the EPS of Suven Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Suven Pharmaceuticals Ltd is 9.45. An EPS is the amount of net income attributed to each share of a common stock.

How is Suven Pharmaceuticals Ltd EPS calculated?

The EPS of Suven Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Suven Pharmaceuticals Ltd report its EPS?

Suven Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Suven Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Suven Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Suven Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Suven Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*